200 related articles for article (PubMed ID: 19509263)
1. Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit.
Bekier ME; Fischbach R; Lee J; Taylor WR
Mol Cancer Ther; 2009 Jun; 8(6):1646-54. PubMed ID: 19509263
[TBL] [Abstract][Full Text] [Related]
2. The ability to survive mitosis in the presence of microtubule poisons differs significantly between human nontransformed (RPE-1) and cancer (U2OS, HeLa) cells.
Brito DA; Rieder CL
Cell Motil Cytoskeleton; 2009 Aug; 66(8):437-47. PubMed ID: 18792104
[TBL] [Abstract][Full Text] [Related]
3. Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy.
Giovinazzi S; Bellapu D; Morozov VM; Ishov AM
Cell Cycle; 2013 Aug; 12(16):2598-607. PubMed ID: 23907120
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis.
Ling YH; Tornos C; Perez-Soler R
J Biol Chem; 1998 Jul; 273(30):18984-91. PubMed ID: 9668078
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents.
Wysong DR; Chakravarty A; Hoar K; Ecsedy JA
Cell Cycle; 2009 Mar; 8(6):876-88. PubMed ID: 19221504
[TBL] [Abstract][Full Text] [Related]
6. Tubulin-binding agents down-regulate matrix metalloproteinase-2 and -9 in human hormone-refractory prostate cancer cells – a critical role of Cdk1 in mitotic entry.
Chang WL; Yu CC; Chen CS; Guh JH
Biochem Pharmacol; 2015 Mar; 94(1):12-21. PubMed ID: 25615907
[TBL] [Abstract][Full Text] [Related]
7. Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells.
Andreassen PR; Margolis RL
J Cell Biol; 1994 Nov; 127(3):789-802. PubMed ID: 7962060
[TBL] [Abstract][Full Text] [Related]
8. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
Kamath K; Jordan MA
Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
[TBL] [Abstract][Full Text] [Related]
9. Mitotic slippage and the subsequent cell fates after inhibition of Aurora B during tubulin-binding agent-induced mitotic arrest.
Tsuda Y; Iimori M; Nakashima Y; Nakanishi R; Ando K; Ohgaki K; Kitao H; Saeki H; Oki E; Maehara Y
Sci Rep; 2017 Dec; 7(1):16762. PubMed ID: 29196757
[TBL] [Abstract][Full Text] [Related]
10. TRAIL inactivates the mitotic checkpoint and potentiates death induced by microtubule-targeting agents in human cancer cells.
Kim M; Liao J; Dowling ML; Voong KR; Parker SE; Wang S; El-Deiry WS; Kao GD
Cancer Res; 2008 May; 68(9):3440-9. PubMed ID: 18451172
[TBL] [Abstract][Full Text] [Related]
11. Arsenite-induced mitotic death involves stress response and is independent of tubulin polymerization.
Taylor BF; McNeely SC; Miller HL; States JC
Toxicol Appl Pharmacol; 2008 Jul; 230(2):235-46. PubMed ID: 18485433
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Bcl-xL sensitizes cells to mitotic blockers, but not mitotic drivers.
Bennett A; Sloss O; Topham C; Nelson L; Tighe A; Taylor SS
Open Biol; 2016 Aug; 6(8):. PubMed ID: 27512141
[TBL] [Abstract][Full Text] [Related]
13. G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodonium.
Scaife RM
Mol Cancer Ther; 2004 Oct; 3(10):1229-37. PubMed ID: 15486190
[TBL] [Abstract][Full Text] [Related]
14. Caspase-3-dependent mitotic checkpoint inactivation by the small-molecule inducers of mitotic slippage SU6656 and geraldol.
Riffell JL; Jänicke RU; Roberge M
Mol Cancer Ther; 2011 May; 10(5):839-49. PubMed ID: 21441410
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells.
Lee EA; Keutmann MK; Dowling ML; Harris E; Chan G; Kao GD
Mol Cancer Ther; 2004 Jun; 3(6):661-9. PubMed ID: 15210851
[TBL] [Abstract][Full Text] [Related]
16. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.
Ditchfield C; Johnson VL; Tighe A; Ellston R; Haworth C; Johnson T; Mortlock A; Keen N; Taylor SS
J Cell Biol; 2003 Apr; 161(2):267-80. PubMed ID: 12719470
[TBL] [Abstract][Full Text] [Related]
17. Gene expression and mitotic exit induced by microtubule-stabilizing drugs.
Chen JG; Yang CP; Cammer M; Horwitz SB
Cancer Res; 2003 Nov; 63(22):7891-9. PubMed ID: 14633718
[TBL] [Abstract][Full Text] [Related]
18. Cells satisfy the mitotic checkpoint in Taxol, and do so faster in concentrations that stabilize syntelic attachments.
Yang Z; Kenny AE; Brito DA; Rieder CL
J Cell Biol; 2009 Sep; 186(5):675-84. PubMed ID: 19720871
[TBL] [Abstract][Full Text] [Related]
19. Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
Matsuhashi A; Ohno T; Kimura M; Hara A; Saio M; Nagano A; Kawai G; Saitou M; Takigami I; Yamada K; Okano Y; Shimizu K
Curr Cancer Drug Targets; 2012 Jul; 12(6):625-39. PubMed ID: 22463590
[TBL] [Abstract][Full Text] [Related]
20. Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents.
Dowling M; Voong KR; Kim M; Keutmann MK; Harris E; Kao GD
Cancer Biol Ther; 2005 Feb; 4(2):197-206. PubMed ID: 15753652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
